2m 2m 2m 2m 2m 2m 2m
CALUMET (CLMT)
NASDAQ
$32.84-$0.41 (-1.23%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.9BMarket Cap
- 109.78%1-Year Change
- Specialty ChemicalsIndustry
CALUMET (CLMT)
$32.84-$0.41 (-1.23%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 4.1B -1.25% | 4.2B N/A | |
Cost of Revenue | 3.9B -1.70% | 4.0B N/A | |
Gross Profit | 245.7M +6.46% | 230.8M N/A | |
Sales and Marketing Expense | 47.9M -14.00% | 55.7M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 148.8M -0.13% | 149.0M N/A | |
Total Operating Expenses | 3.9B -1.70% | 4.0B N/A | |
Operating Profit | 108.7M +1,241.98% | 8.1M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | -235.1M +2.53% | -229.3M N/A | |
Income before Taxes | -126.4M -42.86% | -221.2M N/A | |
Income Taxes | -92.6M -11,675.00% | 800,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | -33.8M -84.77% | -222.0M N/A | |
Net Income from Continuing Operations Applicable to Common | 47.1M 0.00% | 47.1M N/A | |
Basic EPS and Net Income | -0.39 -85.39% | -2.67 N/A | |
Diluted EPS and Net Income | -0.39 -85.39% | -2.67 N/A | |
Basic Weighted Average Shares | 86.8M +4.35% | 83.1M N/A | |
Diluted Weighted Average Shares | 86.8M +4.35% | 83.1M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 125.1M +228.35% | 38.1M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 125.1M +228.35% | 38.1M N/A | |
Total Current Assets | 857.8M +11.98% | 766.0M N/A | |
Accumulated Depreciation | 1.3B +10.54% | 1.2B N/A | |
Property and Plant and Equipment and Net | 1.4B -5.96% | 1.4B N/A | |
Total Long-Term Assets | 104.7M -11.42% | 118.2M N/A | |
Total Assets | 2.7B -2.51% | 2.8B N/A | |
Income Taxes Payable | 17.7M +48.74% | 11.9M N/A | |
Total Short-Term Debt | 156.2M +340.00% | 35.5M N/A | |
Total Current Liabilities | 840.7M -2.65% | 863.6M N/A | |
Total Long-Term Debt | 2.1B +0.61% | 2.1B N/A | |
Total Long-Term Liabilities | 92.8M -15.64% | 110.0M N/A | |
Total Liabilities | 3.2B -1.50% | 3.2B N/A | |
Retained Earnings | -1.6B +2.24% | -1.5B N/A | |
Total Stockholders Equity | -732.7M +2.92% | -711.9M N/A | |
Total Shares Outstanding | 86.8M +0.96% | 86.0M N/A | |
Cash Flow | |||
Cash from Operating Activities | 108.9M +334.70% | -46.4M N/A | |
Capital Expenditures | 52.3M -31.81% | 76.7M N/A | |
Cash from Investing Activities | 44.1M +157.50% | -76.7M N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.2M -95.98% | 154.3M N/A | |
Financials Ratio | |||
Gross Margin | 5.94% N/A | N/A N/A | |
Operating Margin | 2.63% N/A | N/A N/A | |
Return on Assets | -1.24% N/A | N/A N/A | |
Return on Equity | 4.68% N/A | N/A N/A | |
Revenue Growth | -1.25% N/A | N/A N/A | |
Current Ratio | 1.02 N/A | N/A N/A | |
Cash Ratio | 0.15 N/A | N/A N/A | |
Debt-to-Equity Ratio | -3.05 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.83 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow